Titus Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$422K Buy
1,303
+367
+39% +$110K 0.21% 80
2022
Q1
$268K Sell
936
-530
-36% -$136K 0.12% 132
2021
Q4
$405K Hold
1,466
0.18% 88
2021
Q3
$338K Hold
1,466
0.18% 96
2021
Q2
$336K Hold
1,466
0.18% 95
2021
Q1
$274K Hold
1,466
0.16% 106
2020
Q4
$247K Sell
1,466
-300
-17% -$44.8K 0.15% 109
2020
Q3
$261K Buy
1,766
+530
+43% +$82K 0.19% 94
2020
Q2
$203K Buy
+1,236
New +$190K 0.16% 105
2018
Q3
Sell
-2,472
Closed -$211K 101
2018
Q2
$211K Buy
+2,472
New +$203K 0.23% 81
2018
Q1
Sell
-2,472
Closed -$209K 84
2017
Q4
$209K Buy
+2,472
New +$210K 0.24% 72

Other funds holding LLY

Titus Wealth Management's LLY Position: Q2 2022 in Review

Titus Wealth Management increased its Eli Lilly (LLY) stake by 39% in Q2 2022, buying an estimated $110K and bringing the position to 1,303 shares worth $422K. The position accounts for 0.21% of the portfolio, ranked #80.

Titus Wealth Management first reported a position in LLY in Q4 2017 and has held it in 11 quarters since. 2,445 funds tracked by Wall St. Rank hold LLY as of Q2 2022.

  • Titus Wealth Management held 1,303 shares of Eli Lilly worth $422K as of Q2 2022.
  • Titus Wealth Management bought 367 Eli Lilly shares in Q2 2022, an estimated $110K.
  • Eli Lilly made up 0.21% of Titus Wealth Management's portfolio in Q2 2022, its #80 holding.
  • Titus Wealth Management first reported a position in Eli Lilly in Q4 2017 and has held it in 11 quarters since.
  • 2,445 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2022.

Based on Titus Wealth Management's 13F filing for Q2 2022, filed 9 Nov 2022.